Acutus Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Acutus Medical generated cash of -$63,608,000, which is more than the previous year. Cash used in financing activities reached the amount of -$2,664,000 last year. Net change in cash is therefore -$5,148,000.
Cash Flow
| 2018 | -33.78M | -4.74M | 37.41M |
|---|---|---|---|
| 2019 | -55.98M | -70.43M | 126.33M |
| 2020 | -85.16M | -63.82M | 164.43M |
| 2021 | -99.68M | 19.06M | 79.56M |
| 2022 | -85.03M | 104.75M | -12.11M |
| 2023 | -63.60M | 58.55M | -2.66M |
AFIB Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 31.34M | 24.22M | 25.38M | 9.60M | 9.77M | 10.92M |
Operating activities | ||||||
Net income | -39.61M | -39.61M | -117.68M | -101.98M | -97.03M | -47.90M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 874K | 7.12M | 6.89M | 3.90M | 3.16M | 2.12M |
Stock-based compensation expense | 3.03M | 3.4M | 13.75M | 12.10M | 2.99M | 0 |
| Deferred income tax benefit | 3.03M | 3.4M | 13.75M | 12.10M | 2.99M | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -1.07M | -452K | -1.47M | -1.89M | -96K | 26K |
Inventories | -2.48M | 3.08M | -3.87M | -3.89M | -5.42M | 523K |
Accounts payable | 288K | -2.85M | -871K | 2.28M | 2.11M | 18K |
Cash generated by operating activities | -63.60M | -85.03M | -99.68M | -85.16M | -55.98M | -33.78M |
Investing activities | ||||||
Purchases Of Investments | -39.76M | -54.50M | -87.25M | -114.69M | -68.73M | -14.30M |
Investments In Property Plant And Equipment | -219K | -3.98M | -9.97M | -11.22M | -13.39M | -2.03M |
Acquisitions Net | 17M | 70M | -29.03M | 52.59M | -3M | 0 |
Cash generated by investing activities | 58.55M | 104.75M | 19.06M | -63.82M | -70.43M | -4.74M |
Financing activities | ||||||
Common Stock Issued | 29K | 0 | 83.22M | 166.28M | 66.67M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -111K | -111K | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -9.72M | 0 | 0 | 62M | -600K |
Cash used in financing activities | -2.66M | -12.11M | 79.56M | 164.43M | 126.33M | 37.41M |
Net Change In Cash | -5.14M | 7.12M | -1.16M | 15.78M | -173K | -1.15M |
Cash at end of period | 26.2M | 31.34M | 24.22M | 25.38M | 9.60M | 9.77M |
| Data source | Data source | Data source | Data source |